Clearday, Inc. (CLRD)
OTCMKTS: CLRD · Delayed Price · USD
0.660
+0.060 (10.00%)
May 3, 2024, 1:40 PM EDT - Market closed
Clearday Revenue
Clearday had revenue of $7.54M in the twelve months ending September 30, 2023, down -39.13% year-over-year. Revenue in the quarter ending September 30, 2023 was $831.91K, a -72.79% decrease year-over-year. In the year 2022, Clearday had annual revenue of $12.49M, a decrease of -3.05%.
Revenue (ttm)
$7.54M
Revenue Growth
-39.13%
P/S Ratio
2.29
Revenue / Employee
$33,524
Employees
225
Market Cap
17.27M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 12.49M | -393.12K | -3.05% |
Dec 31, 2021 | 12.88M | 226.15K | 1.79% |
Dec 31, 2020 | 12.66M | 12.11M | 2,222.12% |
Dec 31, 2019 | 545.00K | -1.56B | -99.96% |
Dec 31, 2018 | 1.56B | 1.11B | 248.88% |
Dec 31, 2017 | 446.00M | 445.87M | 340,358.02% |
Dec 31, 2016 | 131.00K | -113.00K | -46.31% |
Dec 31, 2015 | 244.00K | -631.76M | -99.96% |
Dec 31, 2014 | 632.00M | -1.08B | -63.04% |
Dec 31, 2013 | 1.71B | -1.53B | -47.17% |
Dec 31, 2012 | 3.24B | 3.23B | 94,659.95% |
Dec 31, 2011 | 3.42M | -3.35M | -49.53% |
Dec 31, 2010 | 6.77M | -10.93M | -61.76% |
Dec 31, 2009 | 17.70M | -6.75B | -99.74% |
Dec 31, 2008 | 6.77B | -6.02B | -47.07% |
Dec 31, 2007 | 12.79B | -4.91B | -27.74% |
Dec 31, 2006 | 17.70B | -3.38B | -16.05% |
Dec 31, 2005 | 21.08B | 4.29B | 25.57% |
Dec 31, 2004 | 16.79B | -21.79B | -56.48% |
Dec 31, 2003 | 38.58B | 20.98B | 119.18% |
Dec 31, 2002 | 17.60B | 10.00B | 131.56% |
Dec 31, 2001 | 7.60B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.33B |
CLRD News
- 1 day ago - Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success - Updated - GlobeNewsWire
- 1 day ago - Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success - GlobeNewsWire
- 9 days ago - Clearday introduces digital assistants in residential communities - GlobeNewsWire
- 4 weeks ago - Clearday to Present at the Emerging Growth Conference on April 4, 2024 - GlobeNewsWire
- 2 months ago - CLEARDAY LIVING IMPLEMENTS SMART TOILET INNOVATION DESIGNED TO IMPROVE RESIDENT HEALTH - GlobeNewsWire
- 6 months ago - San Antonio, Texas Clearday (CLRD-OTCQX) is proud to honor our US Veterans through the Company's Clearday Club in San Antonio, Texas. - GlobeNewsWire
- 8 months ago - Clearday to Participate in Fireside Chat at SHARE Series - GlobeNewsWire
- 8 months ago - Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement - GlobeNewsWire